Data as of Jul 31
| -0.74 / -1.32%|
The 11 analysts offering 12-month price forecasts for Hospira Inc have a median target of 47.00, with a high estimate of 53.00 and a low estimate of 35.00. The median estimate represents a -15.27% decrease from the last price of 55.47.
The current consensus among 16 polled investment analysts is to Hold stock in Hospira Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.